After more than two years of vying for public support for its casino proposal, SL Green Realty is officially out of the running. A Community Advisory Committee on Wednesday voted 4-2 to disapprove SL ...

The 2026 Mercedes-Maybach SL 680 Monogram Series is now in showrooms. It starts as an AMG SL 63 that is not exactly softened up but, rather, further refined. It corners more confidently than the AMG ...

I'm hesistant to call the Adidas Adizero Evo SL the “perfect” running shoe. As a gear tester, I’m constantly on the hunt for the best kicks to recommend anytime anyone asks me what to buy. Usually, ...

Mercedes-Benz customers residing in the Land Down Under have a new individualization program at their disposal - the new Manufaktur Exclusive, available for the Mercedes-Benz and Maybach S-Class, as ...

Is the Adidas Adizero Evo SL the “shoe of the year”? While 2025 isn’t over just yet, it has been the front-runner for such an honor since it went on sale on February 1. That day, I suggested as much ...

Time has been more kind to the 280 SL in the intervening years since that review, largely because the performance and comfort of any car more than five decades old can’t remotely compare to that of ...

Shattuck Labs, Inc. has announced progress in its SL-325 program, with an Investigational New Drug (IND) filing expected in the third quarter of 2025. The company reported a cash balance of ...

The Mercedes-AMG SL 63 has long been one of the most iconic convertible sports cars, and for 2025, a rare special edition is set to make it even more distinctive. Enter the 2025 Mercedes-AMG SL 63 ...

South Africa 191 (Bavuma 70, Asitha 3-44, Kumara 3-70) and 366 for 5 dec (Stubbs 122, Bavuma 113) beat Sri Lanka 42 (Jansen 7-13) and 282 (Chandimal 83, Dhananjaya 59, Jansen 4-73) by 233 runs South ...

After military service a career as war correspondent was on the cards. But then an exclusive bursar programme in automotive journalism came 'a-knockin' - and so a 26-year journey spanning newspapers, ...

CAPLYTA Q3 2024 net product sales were $175.2 million, compared to $125.8 million for the same period in 2023, representing a 39% increase CAPLYTA’s strong prescription uptake continues: Q3 2024 ...